Aiml Resources AI Stock Analysis
Want to see TSE:AIML full AI Analyst Report?
Aiml Resources (AIML) AI Stock Analysis
Aiml Resources
(CNQX:AIML)
The overall score of 38 reflects a company in severe financial distress. The most significant factor is the near-total revenue collapse and insolvent balance sheet, which poses an existential threat. This is compounded by a persistent technical downtrend and a negative P/E ratio that confirms the lack of earnings power. The company is burning cash rapidly with no apparent path to self-sustaining operations.
Aiml Resources (AIML) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 13.43M
- Dividend Yield
- ―
- Average Volume (3M)
- 222.50K
- Price to Earnings (P/E)
- -1.7
- Beta (1Y)
- 1.17
- Revenue Growth
- -73.93%
- EPS Growth
- 23.46%
- Country
- Canada
- Employees
- 3
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Aiml Resources Business Overview & Revenue Model
Company Description
Operating within the digital healthcare sector, AI/ML Innovations Inc. harnesses the power of artificial intelligence (AI) and machine learning (ML). The company's central offering is a patent-pending system for personal health monitoring and managem...
How the Company Makes Money
Reliable, source-verifiable details on Aiml Resources (AIML)'s revenue model, key revenue streams, and material partnerships or drivers of earnings are not available from the context provided. null
Aiml Resources Financial Statement Overview
Summary
Financial performance is critically poor. Revenue has collapsed to near zero, the company is deeply unprofitable with a -76.6% net margin, and the balance sheet is insolvent with negative equity. Accelerating cash burn of -$5.7M TTM indicates an unsustainable business model with no internal funding capacity.
Income Statement
8Very NegativeBalance Sheet
5Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Jul 2026 | Jul 2025 | Jul 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.06K | 83.06K | 167.31K | 600.14K | 487.50K | 65.41K |
| Gross Profit | -554.88K | -2.75M | 162.81K | 294.86K | 466.01K | 65.41K |
| EBITDA | -6.40M | -6.39M | -4.83M | -1.67M | -1.36M | -3.42M |
| Net Income | -6.36M | -6.36M | -4.59M | -3.29M | -1.42M | -3.17M |
Balance Sheet | ||||||
| Total Assets | 2.07M | 2.07M | 3.41M | 329.69K | 1.51M | 2.04M |
| Cash, Cash Equivalents and Short-Term Investments | 257.77K | 257.77K | 2.00M | 216.86K | 14.56K | 525.24K |
| Total Debt | 962.20K | 962.20K | 198.19K | 197.72K | 859.98K | 261.34K |
| Total Liabilities | 2.89M | 2.89M | 855.77K | 1.54M | 1.79M | 1.55M |
| Stockholders Equity | -785.25K | -785.25K | 2.60M | -1.17M | -247.46K | 1.08M |
Cash Flow | ||||||
| Free Cash Flow | -5.41M | -5.41M | -3.99M | -1.64M | -634.28K | -3.02M |
| Operating Cash Flow | -5.41M | -5.41M | -3.99M | -1.64M | -634.28K | -3.02M |
| Investing Cash Flow | -4,669 | -4,669 | -1,151 | -325.98K | -210.64K | -1.14M |
| Financing Cash Flow | 3.67M | 3.67M | 5.78M | 2.16M | 374.37K | 1.27M |
Aiml Resources Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AIML, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and above the 200-day MA of 0.04, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 46.64 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:AIML.
Aiml Resources Peers Comparison
Overall Rating
TSE:NARA42Neutral
TSE:CHS41Neutral
TSE:DMED39Underperform
TSE:UDOC39Underperform
TSE:AIML38Underperform
TSE:ADK38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 42Neutral | CAD 2.53M | -0.87 | 184.91% | ― | ― | 43.30% | |
| 41Neutral | CAD 9.28M | -1.47 | 64.52% | ― | 7.63% | -106.03% | |
| 39Underperform | CAD 2.63M | -1.29 | 739.84% | ― | ― | -28.35% | |
| 39Underperform | CAD 3.89M | -1.19 | 355.56% | ― | 614.03% | 51.97% | |
| 38Underperform | CAD 13.43M | -1.72 | 2759.13% | ― | -73.93% | 23.46% | |
| 38Underperform | CAD 32.51M | -6.54 | 9999.00% | ― | -36.92% | 13.03% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:AIML | Aiml Resources Inc. | 0.04 | 0.00 | 12.50% | |
| TSE:ADK | Diagnos Inc | 0.27 | -0.04 | -12.90% | |
| TSE:CHS | Comprehensive Healthcare Systems Inc | 0.32 | -0.18 | -36.00% | |
| TSE:UDOC | Unidoc Health Corp. | 0.04 | -0.11 | -70.97% | |
| TSE:NARA | PanGenomic Health, Inc. Class A | 0.18 | -0.56 | -75.68% | |
| TSE:DMED | DiagnaMed Holdings Corp. | 0.02 | -0.04 | -69.23% |
Aiml Resources Corporate Events
AIML’s NeuralCloud Partners with Etisense to Embed AI ECG Engine in Preclinical Animal Research
PositiveNeuralCloud Solutions, the wholly owned subsidiary of AI/ML Innovations Inc., has entered into a non-exclusive agreement with Lyon-based Etisense SAS to integrate its MaxYield ECG signal-processing engine into Etisense’s LASA telemetry software. The...
AI/ML Innovations Tightens Governance With New Advance Notice Rules for Director Nominations
PositiveAI/ML Innovations Inc., a global digital health technology firm, specializes in applying artificial intelligence and neural networks to biometric data to generate actionable clinical insights. Through advanced signal processing and deep learning, the...
AI/ML Innovations Converts Service Debt to Equity in Share Issuance
PositiveAI/ML Innovations Inc., a global provider of AI-driven digital health technologies, develops neural-network-based platforms that convert biometric data into clinical insights to support early diagnosis and personalized care. The company is listed on...
AI/ML Innovations Names New CFO and Issues Shares to Settle Debt
PositiveAI/ML Innovations Inc., a global technology firm specializing in artificial intelligence and neural-network solutions for digital health, develops platforms that transform biometric data into clinical insights to improve diagnosis, treatment personal...
AIML’s NeuralCloud Strikes VetMed Deal to Validate MaxYield ECG Tech in Preclinical Cardiac Safety
PositiveAI/ML Innovations’ subsidiary NeuralCloud Solutions has signed a binding commercial term sheet and service level agreement with VetMed Consultants to evaluate the use of its MaxYield ECG signal-processing technology in preclinical cardiac safety work...
NeuralCloud and RKS Medical Partner to Pilot Integrated CardioYield Cardiac Monitoring Platform
PositiveNeuralCloud Solutions, a subsidiary of AI/ML Innovations Inc., has entered a strategic partnership with Toronto-based RKS Medical Technologies to pair NeuralCloud’s CardioYield software with RKS’s myPatch wireless Holter monitoring devices. The colla...
AI/ML Innovations Launches Quantum Soma Contactless Quantum Biosensing Initiative
PositiveAI/ML Innovations has launched Quantum Soma, a new project to develop a contactless quantum biosensing platform that marries Dynex Quantum Technologies’ NV-diamond quantum sensors with AIML’s MaxYield signal-intelligence engine. The initiative aims t...
AI/ML’s NeuralCloud Taps Former FDA Lead Reviewer to Head Regulatory Strategy
PositiveAI/ML Innovations’ subsidiary NeuralCloud has appointed former U.S. FDA lead reviewer and scientist Dr. Mehmet A. Kosoglu as Head of Regulatory, adding more than 15 years of experience in medical devices, SaMD, digital health and FDA policy to its le...
NeuralCloud to Pilot AI ECG Platforms with Island Mobile Cardiology Testing
PositiveNeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has signed a non-binding commercial term sheet with Island Mobile Cardiology Testing to run a pilot of its MaxYield and CardioYield platforms in a mobile Holter monitoring workflow o...
AI/ML Innovations Plans $2 Million Private Placement to Fund Digital Health Expansion
PositiveAI/ML Innovations Inc., a global AI-driven digital health company, develops proprietary platforms that apply neural networks and deep learning to complex biometric data. Its technology is designed to generate actionable clinical insights that support...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 11, 2026